0 items / CHF0.00

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

0 items / CHF0.00

jakavi_img_1_1

Click to enlarge

Previous product

Zynlonta (loncastuximab tesirine-lpyl) CHF27,746.55

Back to products

Next product

<img width="600" height="600" src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/xalkori_img-600x600.png" class="attachment-woocommerce_thumbnail size-woocommerce_thumbnail" alt="" srcset="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/xalkori_img-600x600.png 600w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/xalkori_img-300x300.png 300w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/xalkori_img-150x150.png 150w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/xalkori_img.png 700w" sizes="(max-width: 600px) 100vw, 600px" />

Xalkori (crizotinib) CHF4,927.62

Jakavi (ruxolitinib)

CHF2,272.99

Jakavi (ruxolitinib) is a prescription medicine used to treat adults with myelofibrosis (MF), Polycythaemia vera (PV), or adult and pediatric patients 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD.

Add to wishlist

Category: Oncology

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Jakavi (ruxolitinib)”

Start typing to see products you are looking for.

No account yet?

Create an Account